首页> 外文期刊>AIDS Research and Human Retroviruses >Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan.
【24h】

Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan.

机译:塔吉克斯坦杜尚别注射吸毒者中正在出现的1型HIV和HCV流行病的特征。

获取原文
获取原文并翻译 | 示例
       

摘要

This study aimed to determine HIV, HCV, and syphilis prevalence and correlates, and to characterize the molecular epidemiology of HIV-1 among injecting drug users (IDUs) in Dushanbe, Tajikistan. A cross-sectional study assessing risk factors for HIV and HCV through an interview administered survey was conducted. A total of 491 active adult IDUs were recruited from May to November 2004 in Dushanbe, Tajikistan. HIV-1 antibody status was determined with rapid testing and confirmed with ELISA. HCV antibody testing was conducted using a BIOELISA HCV kit. HIV-1 subtyping was done on a subset with full-length sequencing. Correlates of HIV and HCV infection were assessed using logistic regression. Overall prevalence of HIV was 12.1%, HCV was 61.3%, and syphilis was 15.7%. In a multivariate logistic regression model controlling for gender and ethnicity, daily injection of narcotics [odds ratio (OR) OR 3.22] and Tajik nationality (OR 7.06) were significantly associated with HIV status. Tajik nationality (OR 1.91), history of arrest (OR 2.37), living/working outside Tajikistan in the past 10 years (OR 2.43), and daily injection of narcotics (OR 3.26) were significantly associated with HCV infection whereas being female (OR 0.53) and always using a sterile needle (OR 0.47) were inversely associated with HCV infection. Among 20 HIV-1-positive IDU with specimens available for typing, 10 were subtype A, 9 were CRF02_AG, and one was an A-CRF02_AG recombinant. Epidemics of HIV-1, HCV, and drug use are underway in Dushanbe. The molecular epidemiology is distinctive, with West African variants accounting for roughly 50% of prevalent infections. Targeted prevention programs offering both needle exchange programs and opiate substitution therapies are urgently called for to prevent the further spread of HIV and HCV in Tajikistan.
机译:这项研究旨在确定塔吉克斯坦杜尚别注射吸毒者(IDU)中HIV-1,HCV和梅毒的患病率及其相关性,并表征HIV-1的分子流行病学。进行了一项横断面研究,通过接受访谈的调查来评估HIV和HCV的危险因素。 2004年5月至11月,在塔吉克斯坦杜尚别招募了491名活跃的成人吸毒者。通过快速测试确定HIV-1抗体状态,并通过ELISA进行确认。 HCV抗体测试是使用BIOELISA HCV试剂盒进行的。 HIV-1亚型分型是通过全长测序完成的。使用logistic回归评估了HIV和HCV感染的相关性。 HIV的总体患病率为12.1%,HCV为61.3%,梅毒为15.7%。在控制性别和种族的多元逻辑回归模型中,每天注射毒品[比值比(OR)OR 3.22]和塔吉克族裔(OR 7.06)与HIV感染状况显着相关。塔吉克族(OR 1.91),被捕史(OR 2.37),过去10年在塔吉克斯坦以外的生活/工作(OR 2.43)以及每天注射毒品(OR 3.26)与HCV感染显着相关,而女性为HCV感染0.53)和始终使用无菌针头(OR 0.47)与HCV感染呈负相关。在20个HIV-1阳性IDU中,有可分型的标本,其中10个是亚型A,9个是CRF02_AG,一个是A-CRF02_AG重组体。杜尚别地区正在发生HIV-1,HCV和毒品的流行病。分子流行病学与众不同,西非变种约占流行感染的50%。为防止艾滋病毒和丙肝病毒在塔吉克斯坦的进一步蔓延,迫切需要有针对性的预防计划,提供针头更换计划和鸦片替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号